The effectiveness of RIA therapy Cancer thyroid Doses 30 mCi , 50 mCi

Name: The effectiveness of RIA therapy Cancer thyroid Doses 30 mCi , 50 mCi
Brand: LAP LAMBERT Academic Publishing
Availability: OutOfStock
Rating: 5 (1 reviews)

By Abdelhadi Benabdessadok

0 - Default Title

Description

RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure.

Product details

Binding:: Paperback
Number of Pages:: 80
Release Date:: 2025-12-18
Publication Date:: 2025-12-18
Publisher:: LAP LAMBERT Academic Publishing
Languages:: Original: English
ISBN10:: 620926445X
ISBN13:: 9786209264450
Weight:: 137 g
Height:: 150 cm
Width:: 220 cm
Thickness:: 5 cm

Buy on Amazon

Currently sold out